Hot Features
Premium
Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Período:
Tipo de Línea:
| Volume | 307,086 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 1.47 | Mínimo Máximo |
|||||
| Minimo del Dia | 1.43 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Marinus Pharmaceuticals Inc | MRNS | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| -0.0299 | -2.05% | 1.4301 | 23:00:04 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 1.45 | 1.43 | 1.47 | 1.465 | 1.46 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 2,787 | 307,086 | US$ 1.44 | US$ 442,822 | - | 1.11 - 11.26 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 18:43:29 | 5 | US$ 1.50 | USD |
Información Financiera Marinus Pharmaceuticals Inc MRNS
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 79.78M | 54.64M | - | 30.99M | -141.41M | -2.59 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Marinus Pharmaceuticals Inc MRNS
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 06/6/2024 | 15:55 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 06/6/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 24/5/2024 | 05:35 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17/5/2024 | 06:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17/5/2024 | 06:00 | Business Wire | Marinus Pharmaceuticals Announces Key Business Updates for.. |
| 08/5/2024 | 06:07 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 08/5/2024 | 06:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 08/5/2024 | 06:00 | Business Wire | Marinus Pharmaceuticals Provides Business Update and Reports.. |
| 02/5/2024 | 07:00 | Business Wire | Marinus Pharmaceuticals to Present at the RBC Capital.. |
| 01/5/2024 | 07:00 | Business Wire | Marinus Pharmaceuticals to Provide Business Update and.. |
| 15/4/2024 | 06:00 | Business Wire | Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE.. |
| 05/4/2024 | 15:00 | Business Wire | Marinus Pharmaceuticals Announces Inducement Grants Under.. |
Histórico de Datos MRNS
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.49 | 1.635 | 1.43 | 1.52 | 594,327 | -0.0599 | -4.02% |
| 1 Month | 1.31 | 1.635 | 1.27 | 1.43 | 1,002,825 | 0.1201 | 9.17% |
| 3 Months | 9.05 | 9.41 | 1.11 | 1.82 | 2,229,440 | -7.62 | -84.20% |
| 6 Months | 8.91 | 11.26 | 1.11 | 3.32 | 1,275,913 | -7.48 | -83.95% |
| 1 Year | 10.64 | 11.26 | 1.11 | 4.95 | 956,542 | -9.21 | -86.56% |
| 3 Years | 18.80 | 19.83 | 1.11 | 6.27 | 559,658 | -17.37 | -92.39% |
| 5 Years | 4.18 | 20.04 | 0.77 | 4.43 | 1,040,092 | -2.75 | -65.79% |
